An anti-inflammation injectable drug can reduce mucus buildup and improve breathing among asthma patients, a new clinical trial says. Results found half as many patients had mucus-plugged airways ...

Monthly injection with tezepelumab helped 90% of patients with severe asthma reduce intake of daily steroid tablets. The corresponding study was published in The Lancet Respiratory Medicine. “In this ...

People with severe asthma sometimes rely on daily steroid pills, which raise the risk of diabetes, infections and bone problems. Now, a study supports the idea that a monthly antibody injection is a ...

A twice-yearly injection that could prevent thousands of asthma patients from suffering life-threatening attacks will go on sale in Britain within months. Trials show the ‘ultra-long-acting’ drug, ...

An anti-inflammation injectable drug can reduce mucus buildup and improve breathing among asthma patients, a new clinical trial says. The drug dupilumab (Dupixent) effectively clears up airways ...

Biological drugs have been a game-changer for people with severe asthma, helping them breathe easier and live more comfortably. But researchers at Karolinska Institutet have uncovered a surprising ...

GLP1 agonist drugs, commonly known by brand names such as Ozempic and Mounjaro, reduce asthma symptoms in obese people according to a new study from the University of Aberdeen and the Observational ...

Managing asthma often requires a two-pronged approach — long-term medicines to prevent attacks and rescue strategies to stop attacks when they happen. It’s important to avoid triggers and monitor ...

An asthma medication coverage policy by Health Care Services Corp. and its Illinois health plans that may lead to more at-home self-injections is meeting resistance from allergists, patients and an ...

Exercise-induced bronchoconstriction (EIB) is a temporary narrowing of the airways triggered by physical activity. It affects up to 90% of children with chronic asthma and happens when cold, dry air ...